BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schnapp A, Harel M, Cayam-rand D, Cassuto H, Polyansky L, Aran A. A Placebo-Controlled Trial of Cannabinoid Treatment for Disruptive Behavior in Children and Adolescents with Autism Spectrum Disorder: Effects on Sleep Parameters as Measured by the CSHQ. Biomedicines 2022;10:1685. [DOI: 10.3390/biomedicines10071685] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 de Camargo RW, de Novais Júnior LR, da Silva LM, Meneguzzo V, Daros GC, da Silva MG, de Bitencourt RM. Implications of the endocannabinoid system and the therapeutic action of cannabinoids in autism spectrum disorder: A literature review. Pharmacol Biochem Behav 2022;221:173492. [PMID: 36379443 DOI: 10.1016/j.pbb.2022.173492] [Reference Citation Analysis]
2 Harris E. Null and Noteworthy: Mind reading, specialist shortage, sleep problems source. Spectrum 2022. [DOI: 10.53053/cyom7671] [Reference Citation Analysis]